Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Signe Neldeborg

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 27, 2019
Rapid and Efficient Gene Deletion by CRISPR/Cas9Signe Neldeborg, Lin Lin, Magnus Stougaard, et al.
Journal of Crohn'S & Colitis|June 26, 2026
Limited placental transfer and clearance of risankizumab by 6 months following in utero exposureChristina Balmer, Julie Korgaard, Charlotte Henneberg Holmboe, et al.
Leukemia|July 18, 2023
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivoSigne Neldeborg, Johannes Frasez Soerensen, Charlotte Thornild Møller, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 27, 2019
Rapid and Efficient Gene Deletion by CRISPR/Cas9Signe Neldeborg, Lin Lin, Magnus Stougaard, et al.
Journal of Crohn'S & Colitis|June 26, 2026
Limited placental transfer and clearance of risankizumab by 6 months following in utero exposureChristina Balmer, Julie Korgaard, Charlotte Henneberg Holmboe, et al.
Leukemia|July 18, 2023
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivoSigne Neldeborg, Johannes Frasez Soerensen, Charlotte Thornild Møller, et al.
Pageof 1